Der Urologe B

, Volume 40, Issue 1, pp 83–92

Progressionshemmung bei chronischen Nierenerkrankungen

  • G. Heine
  • M. Girndt
  • M. K. Kuhlmann
  • H. Köhler
Article
  • 20 Downloads

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Attman PO (1998) Progression of renal failure and lipids — is there evidence for a link in humans? Nephrol Dial Transplant 13:545–547PubMedCrossRefGoogle Scholar
  2. 2.
    Black HR, Zeevi GR, Silten RM, Walker-Smith GJ (1983) Effect of heavy cigarette smoking on renal and myocardial arterioles. Nephron 34:173–179PubMedCrossRefGoogle Scholar
  3. 3.
    Brenner BM (1985) Nephron adaptation to renal injury or ablation. Am J Physiol 249:F324–F337PubMedGoogle Scholar
  4. 4.
    Burton C, Harris KP (1996) The Role of Proteinuria in the Progression of Chronic Renal Failure. Am J Kidney Dis 27:765–775PubMedCrossRefGoogle Scholar
  5. 5.
    Buter H, Hemmelder MH, Navis G, de Jong PE, de Zeeuw D (1998) The blunting of the antiproteinuric efficacy of ACE inhibition by high sodium intake can be restored by hydrochlorothiazide. Nephrol Dial Transplant 13:1682–1685PubMedCrossRefGoogle Scholar
  6. 6.
    Chase HP, Garg SK, Marshall G, Berg CL, Harris S, Jackson WE, Hamman RE (1991) Cigarette smoking increases the risk of albuminuria among subjects with type I diabetes. JAMA 265:614–617PubMedCrossRefGoogle Scholar
  7. 7.
    Dworkin LD, Benstein JA, Parker M, Tolbert E, Feiner HD (1993) Calcium antagonists and converting enzyme inhibitors reduce renal injury by different mechanisms. Kidney Int 43:808–814PubMedCrossRefGoogle Scholar
  8. 8.
    Gansevoort RT, Sluiter WJ, Hemmelder MH, de Zeeuw D, de Jong PE (1995) Antiproteinuric effect of blood-pressure-lowering agents: a meta-analysis of comparative trials. Nephrol Dial Transplant 10:1963–1974PubMedGoogle Scholar
  9. 9.
    GISEN group (1997) Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. Lancet 349:1857–1863CrossRefGoogle Scholar
  10. 10.
    Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S, Menard J, Rahn KH, Weder H, Westerling S (1998) Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 351: 1755–1562PubMedCrossRefGoogle Scholar
  11. 11.
    Kasiske BL, Lakatua JDA, Ma JZ, Louis TA (1998) A Meta-Analysis of the Effects of Dietary Protein Restriction on the Rate of Decline in Renal Function. Am J Kidney Dis 31:954–961PubMedCrossRefGoogle Scholar
  12. 12.
    Keane WF (1993) Lipids and the kidney. Kidney Int 46:910–920CrossRefGoogle Scholar
  13. 13.
    Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker L, Kusek JW, Striker G for the modification of diet in renal disease study group (1994) The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. N Engl J Med 330: 877–884PubMedCrossRefGoogle Scholar
  14. 14.
    Lewis EJ, Hunsicker LG, Bain RP, Rohde RD (1993) The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy. N Engl J Med 329: 1456–1462PubMedCrossRefGoogle Scholar
  15. 15.
    Maschio G, Alberti D, Janin G, Locatelli F, Mann JF, Motolese M, Ponticelli C, Ritz E, Zucchelli P (1996) Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group. N Engl J Med 334: 939–945PubMedCrossRefGoogle Scholar
  16. 16.
    Massy ZA, Nguyen Khoa T, Lacour B, Descamps-Latscha B, Khoa Man N, Jungers P (1999) Dyslipidaemia and the progression of renal disease in chronic renal failure patients. Nephrol Dial Transplant 14: 2392–2406PubMedCrossRefGoogle Scholar
  17. 17.
    Obrador GT, Pereira BJ (1998) Early referral to the nephrologist and timely initiation of renal replacement therapy: a paradigm shift in the management of patients with chronic renal failure. Am J Kidney Dis 31:398–417PubMedCrossRefGoogle Scholar
  18. 18.
    Orth SR, Stöckmann A, Conradt C, Ritz E (1998) Smoking as a risk factor for end-stage renal failure in men with primary renal disease. Kidney Int 54:926–931PubMedCrossRefGoogle Scholar
  19. 19.
    Peterson JC, Adler S, Burkart JM, Greene T, Hebert LA, Hunsicker LG, King AJ, Klahr S, Massry SG, Seifter JL (1995) Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Ann Intern Med 123:754–762PubMedCrossRefGoogle Scholar
  20. 20.
    Ruggenenti P, Perna A, Mosconi L, Pisoni R, Remuzzi G for the GISEN study group (1998) Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies. Kidney Int 53: 1209–1216PubMedCrossRefGoogle Scholar
  21. 21.
    Stiefel M, Verberckmoes R, Ritz E (1989) Is asymptomatic hyperuricemia in kidney-failure patients in need of therapy? Dtsch Med Wochenschr 114:964–968PubMedCrossRefGoogle Scholar
  22. 22.
    Strutz F, Müller GA (1999) Interstitial Pathomechanisms Underlying Progressive Tubulointerstitial Damage. Kidney Blood Press Res 22: 71–80PubMedCrossRefGoogle Scholar
  23. 23.
    Throssell D, Brown J, Harris KPG, Walls J (1995) Metabolic acidosis does not contribute to chronic renal injury in the rat. Clin Sci 89:643–650PubMedGoogle Scholar
  24. 24.
    United States Renal Data System.USRDS 1995 Annual Data Report. U. S. Department of Health and Human Services.The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, August 1995Google Scholar
  25. 25.
    Weidmann P, Schneider M, Böhler L (1995) Therapeutic efficacy of different antihypertensive drugs in human diabetic nephropathy: an updated meta-analysis. Nephrol Dial Transplant (Suppl 9): 39-45Google Scholar
  26. 26.
    Wrenger E, Bahlmann J, Floege J (1996) Harnsäure und tubulo-interstitielle Nierenerkrankungen. Internist 37:1137–1142PubMedGoogle Scholar
  27. 27.
    Zucchelli P, Zuccala A, Borghi M, Fusaroli M, Sasdelli M, Stallone C, Sanna G, Gaggi R (1992) Long-term comparison between captopril and nifedipin in the progression of renal insufficiency. Kidney Int 42: 452–458PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2000

Authors and Affiliations

  • G. Heine
    • 1
  • M. Girndt
    • 1
  • M. K. Kuhlmann
    • 1
  • H. Köhler
    • 1
  1. 1.Innere Medizin IV, Schwerpunkt NephrologieUniversitätskliniken des SaarlandesHomburg/Saar

Personalised recommendations